MedTrace Logo

Peritoneal Ultrafiltration to Treat Congestive Heart Failure

NCT02829450 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2016-07-12

No results posted yet for this study

Summary

The purpose of this study is to determine whether the treatment of peritoneal ultrafiltration can improve survival and quality of life of refractory congestive heart failure with special accent on preserving residual renal function and peritoneal membrane characteristics/

Conditions

Interventions

OTHER

peritoneal ultrafiltration

Peritoneal fluids should be inserted intraperitoneally for several hours dwell

Sponsors & Collaborators

  • Soroka University Medical Center

    lead OTHER

Principal Investigators

  • Marina Vorobiov, MD PhD · Soroka UMC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2020-10-31
Completion
2020-10-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02829450 on ClinicalTrials.gov